When people hear botulinum toxin, they often think one of two things: a cosmetic that makes frown lines disappear or
Continue reading »
Home »
Fampyra
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FAMPYRA – CMI 11016 (fam-peer-a) Fampridine (fam-pri-deen)
Continue reading »
DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board
Continue reading »
Botulism breakthrough? Taming botulinum toxin to deliver therapeutics
While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum—the
Continue reading »
Researchers identify three drugs as possible therapeutics for COVID-19
Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified
Continue reading »
With many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, logistical
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is
Continue reading »
Covid-19: New probe that mimics coronavirus may speed up drug discovery
Scientists have developed a new tool that mimics how the novel coronavirus which causes Covid-19 enters and infects cells, an
Continue reading »